TIGIT and hematopoietic and lymphoid cell neoplasm: TIGIT stands out as a highly expressed marker on exhausted NK and T cells, and its high expression was involved in disease progression and the immune escape in various hematological tumors, indicating the promising value of TIGIT blockade treatment [48, 168–173].